Innovent Biologics, Inc. (IVBIY)
OTCMKTS · Delayed Price · Currency is USD
39.50
0.00 (0.00%)
At close: Jul 14, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $18.71 billion as of July 16, 2025. Its market cap has increased by 141.36% in one year.
Market Cap
18.71B
Enterprise Value
18.02B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$39.50
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 18.71B, an increase of 691.27%. That is a compound annual growth rate of 36.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 553.58M |
| Glass House Brands | 545.56M |
| CytoDyn | 394.14M |
| American Oncology Network | 343.79M |